BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

734 related articles for article (PubMed ID: 17662378)

  • 1. Risk factors for benign, borderline and invasive mucinous ovarian tumors: epidemiological evidence of a neoplastic continuum?
    Jordan SJ; Green AC; Whiteman DC; Webb PM;
    Gynecol Oncol; 2007 Nov; 107(2):223-30. PubMed ID: 17662378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for benign serous and mucinous epithelial ovarian tumors.
    Jordan SJ; Green AC; Whiteman DC; Webb PM
    Obstet Gynecol; 2007 Mar; 109(3):647-54. PubMed ID: 17329516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of reproductive factors, oral contraceptive use and selected lifestyle factors with the risk of ovarian borderline tumors: a Danish case-control study.
    Huusom LD; Frederiksen K; Høgdall EV; Glud E; Christensen L; Høgdall CK; Blaakaer J; Kjaer SK
    Cancer Causes Control; 2006 Aug; 17(6):821-9. PubMed ID: 16783610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cigarette smoking and risk of epithelial ovarian cancer.
    Rossing MA; Cushing-Haugen KL; Wicklund KG; Weiss NS
    Cancer Causes Control; 2008 May; 19(4):413-20. PubMed ID: 18080774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for epithelial borderline ovarian tumors: results of a Swedish case-control study.
    Riman T; Dickman PW; Nilsson S; Correia N; Nordlinder H; Magnusson CM; Persson IR
    Gynecol Oncol; 2001 Dec; 83(3):575-85. PubMed ID: 11733975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Case-control study of borderline ovarian tumors: reproductive history and exposure to exogenous female hormones.
    Harlow BL; Weiss NS; Roth GJ; Chu J; Daling JR
    Cancer Res; 1988 Oct; 48(20):5849-52. PubMed ID: 3167840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different risk factor profiles for mucinous and nonmucinous ovarian cancer: results from the Danish MALOVA study.
    Soegaard M; Jensen A; Høgdall E; Christensen L; Høgdall C; Blaakaer J; Kjaer SK
    Cancer Epidemiol Biomarkers Prev; 2007 Jun; 16(6):1160-6. PubMed ID: 17548679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for ovarian cancer histotypes.
    Chiaffarino F; Parazzini F; Bosetti C; Franceschi S; Talamini R; Canzonieri V; Montella M; Ramazzotti V; Franceschi S; La Vecchia C
    Eur J Cancer; 2007 May; 43(7):1208-13. PubMed ID: 17376671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Height, age at menarche, and risk of epithelial ovarian cancer.
    Jordan SJ; Webb PM; Green AC
    Cancer Epidemiol Biomarkers Prev; 2005 Aug; 14(8):2045-8. PubMed ID: 16103459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical factors and biomarkers in ovarian tumors development.
    Vrabie CD; Petrescu A; Waller M; Dina I
    Rom J Morphol Embryol; 2008; 49(3):327-38. PubMed ID: 18758637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endometrioid and clear cell ovarian cancers: a comparative analysis of risk factors.
    Nagle CM; Olsen CM; Webb PM; Jordan SJ; Whiteman DC; Green AC; ;
    Eur J Cancer; 2008 Nov; 44(16):2477-84. PubMed ID: 18707869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histologic types of epithelial ovarian cancer: have they different risk factors?
    Kurian AW; Balise RR; McGuire V; Whittemore AS
    Gynecol Oncol; 2005 Feb; 96(2):520-30. PubMed ID: 15661246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KRAS and BRAF mutations in ovarian tumors: a comprehensive study of invasive carcinomas, borderline tumors and extraovarian implants.
    Mayr D; Hirschmann A; Löhrs U; Diebold J
    Gynecol Oncol; 2006 Dec; 103(3):883-7. PubMed ID: 16806438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Second neoplasms after invasive and borderline ovarian cancer.
    Levi F; Randimbison L; Blanc-Moya R; La Vecchia C
    Eur J Cancer Prev; 2009 Jun; 18(3):216-9. PubMed ID: 19491608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical characteristics and prognosis of mucinous tumors of the ovary.
    Kikkawa F; Nawa A; Kajiyama H; Shibata K; Ino K; Nomura S
    Gynecol Oncol; 2006 Oct; 103(1):171-5. PubMed ID: 16546243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical staining of GLUT1 in benign, borderline, and malignant ovarian epithelia.
    Kalir T; Wang BY; Goldfischer M; Haber RS; Reder I; Demopoulos R; Cohen CJ; Burstein DE
    Cancer; 2002 Feb; 94(4):1078-82. PubMed ID: 11920478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reproductive risk factors for mucinous and non-mucinous epithelial ovarian cancer.
    Wittenberg J; Cook LS; Rossing MA; Weiss NS
    Epidemiology; 1999 Nov; 10(6):761-3. PubMed ID: 10535792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucinous tumors of the ovary: a review.
    Hart WR
    Int J Gynecol Pathol; 2005 Jan; 24(1):4-25. PubMed ID: 15626914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beyond parity: association of ovarian cancer with length of gestation and offspring characteristics.
    Jordan SJ; Green AC; Nagle CM; Olsen CM; Whiteman DC; Webb PM; ;
    Am J Epidemiol; 2009 Sep; 170(5):607-14. PubMed ID: 19638480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Caffeine, alcohol, smoking, and the risk of incident epithelial ovarian cancer.
    Tworoger SS; Gertig DM; Gates MA; Hecht JL; Hankinson SE
    Cancer; 2008 Mar; 112(5):1169-77. PubMed ID: 18213613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.